(Q41713926)

7 October 2017

1 reference

title

Pitfalls in the diagnosis and management of Lyme disease (English)

1 reference

7 October 2017

0 references

Sigal LH

1

1 reference

7 October 2017

publication date

1 February 1998

1 reference

7 October 2017

published in

Arthritis & Rheumatology

1 reference

7 October 2017

volume

41

1 reference

7 October 2017

issue

2

1 reference

7 October 2017

page(s)

195-204

1 reference

Risk of urban Lyme disease enhanced by the presence of rats

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Lyme carditis: cardiac abnormalities of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Lyme Disease Associated with Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Nervous system Lyme borreliosis--revisited [corrected; erratum to be published]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Western blotting in the serodiagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Treatment of the Early Manifestations of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199802%2941%3A2%3C195%3A%3AAID-ART3%3E3.0.CO%3B2-Y

10.1002/1529-0131(199802)41:2<195::AID-ART3>3.0.CO;2-Y

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference